Alcresta

Alcresta

Alcresta

Alcrestas enzyme expertise and proprietary platform enables novel products for those with compromised pancreatic output and malabsorption.
Founded
2011
Raised
$49.4M
Follow us
Alexa global traffic share
Latest funding
$49,390,000
Venture capital - 2016
Team Size
1–10
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Alcresta makes some noise.